TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Johnson Fistel Investigates Fairness of Proposed Sale of Metsera

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Johnson Fistel, Pllp
Johnson Fistel Investigates Fairness of Proposed Sale of Metsera

Law firm Johnson Fistel launched an investigation into potential fiduciary duty breaches by Metsera's board regarding its proposed sale to Pfizer at $47.50 per share, which is significantly below Wall Street analyst projections.

Insights
MTSR   negative

Proposed merger price ($47.50) is substantially lower than analyst estimates (average $63.50, high $77.00), suggesting potential undervaluation of the company